Edizer, D. Et Al. 2024. Effects of VDR and CYP24A1 gene polymorphisms on the outcome of supraglottic larynx cancer.. European review for medical and pharmacological sciences , vol.28, no.6 , 2168-2178.

Edizer, D., Leblebici, A., Ergun, U., Yilmaz, F., Koc, A., Basbinar, Y., ... Ellidokuz, E.(2024). Effects of VDR and CYP24A1 gene polymorphisms on the outcome of supraglottic larynx cancer.. European review for medical and pharmacological sciences , vol.28, no.6, 2168-2178.

Edizer, D.T. Et Al. "Effects of VDR and CYP24A1 gene polymorphisms on the outcome of supraglottic larynx cancer.," European review for medical and pharmacological sciences , vol.28, no.6, 2168-2178, 2024

Edizer, D.T. Et Al. "Effects of VDR and CYP24A1 gene polymorphisms on the outcome of supraglottic larynx cancer.." European review for medical and pharmacological sciences , vol.28, no.6, pp.2168-2178, 2024

Edizer, D. Et Al. (2024) . "Effects of VDR and CYP24A1 gene polymorphisms on the outcome of supraglottic larynx cancer.." European review for medical and pharmacological sciences , vol.28, no.6, pp.2168-2178.

@article{article, author={D.T. Edizer Et Al. }, title={Effects of VDR and CYP24A1 gene polymorphisms on the outcome of supraglottic larynx cancer.}, journal={European review for medical and pharmacological sciences}, year=2024, pages={2168-2178} }